1. Gadoliniumâa specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?;Grobner;Nephrol Dial Transplant,2006
2. Wollanka H, Weidenmaier W, Giersig C. NSF after Gadovist exposure: a case report and hypothesis of NSF development. Nephrol Dial Transplant 2009. DOI: 10.1093/ndt/gfp4g4.
3. United States Food and Drug Administration. FDA requests boxed warning for contrast agents used to improve MRI images. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108919.htm Accessed September 21, 2009.
4. Incidence of nephrogenic systemic fibrosis at two large medical centers;Prince;Radiology,2008
5. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessmentâreport of 33 cases;Perez-Rodriguez;Radiology,2009